|
|
 Previous Article | Table of Contents | Next Article 
An Allelic Association Implicates Myeloperoxidase in the Etiology of Acute Promyelocytic Leukemia
Wanda F. Reynolds,
Eric Chang,
Dan Douer,
Edward D. Ball, and
Vikas Kanda
From the Sidney Kimmel Cancer Center, San Diego; the Division of Hematology, School of Medicine, University of Southern California, Norris Cancer Hospital, Los Angeles, CA; and the Department of Medicine, University of Pittsburg Medical Center, Pittsburg, PA.
Myeloperoxidase (MPO) catalyzes a reaction between chloride and hydrogen peroxide to generate hypochlorous acid and other reactive compounds that have been linked to DNA damage. The MPO gene is expressed at high levels in normal myeloid precursors and in acute myeloid leukemias (AMLs) which are clonal derivatives of myeloid precursors that have lost the ability to differentiate into mature blood cells. Two MPO alleles differ at -463 G/A within a cluster of nuclear receptor binding sites in an Alu element. The -463 G creates a stronger SP1 binding site and retinoic acid (RA) response element (RARE) in the allele termed Sp. In this study, we investigate potential links between MPO genotype, MPO expression level, and myeloid leukemia. The SpSp MPO genotype is shown to correlate with increased MPO mRNA levels in primary myeloid leukemia cells. This higher-expressing SpSp genotype is further shown to be overrepresented in acute promyelocytic leukemia-M3 (APL-M3) and AML-M4, suggesting that higher levels of MPO are associated with an increased risk for this subset of leukemias.
Blood, Vol. 90 No. 7 (October 1), 1997:
pp. 2730-2737
© 1997 by The American Society of Hematology.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
N. Katakami, K. Sakamoto, H. Kaneto, M. Matsuhisa, K. Ohno, I. Shimizu, F. Ishibashi, T. Osonoi, A. Kashiwagi, R. Kawamori, et al.
Cumulative Effect of Oxidative Stress-Related Gene Polymorphisms on Myocardial Infarction in Type 2 Diabetes
Diabetes Care,
May 1, 2009;
32(5):
e55 - e55.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J.-Y. Choi, M. L. Neuhouser, M. J. Barnett, C.-C. Hong, A. R. Kristal, M. D. Thornquist, I. B. King, G. E. Goodman, and C. B. Ambrosone
Iron intake, oxidative stress-related genes (MnSOD and MPO) and prostate cancer risk in CARET cohort
Carcinogenesis,
May 1, 2008;
29(5):
964 - 970.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Atzeni, L. Boiardi, B. Casali, E. Farnetti, P. Sarzi-Puttini, N. Pipitone, I. Olivieri, F. Cantini, F. Salvi, R. La Corte, et al.
Lack of association of the 463 G/A myeloperoxidase promoter polymorphism with Behcet's disease in Italian patients
Rheumatology,
October 1, 2007;
46(10):
1547 - 1550.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Bolufer, M. Collado, E. Barragan, J. Cervera, M.-J. Calasanz, D. Colomer, J. Roman-Gomez, and M. A. Sanz
The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia
Haematologica,
March 1, 2007;
92(3):
308 - 314.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. W. Chen, M. Querol Sans, A. Bogdanov Jr, and R. Weissleder
Imaging of myeloperoxidase in mice by using novel amplifiable paramagnetic substrates.
Radiology,
August 1, 2006;
240(2):
473 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. M. Knaapen, N. Gungor, R. P. F. Schins, P. J. A. Borm, and F. J. Van Schooten
Neutrophils and respiratory tract DNA damage and mutagenesis: a review
Mutagenesis,
July 1, 2006;
21(4):
225 - 236.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. B. Ambrosone, J. Ahn, K. K. Singh, H. Rezaishiraz, H. Furberg, C. Sweeney, B. Coles, and A. Trovato
Polymorphisms in Genes Related to Oxidative Stress (MPO, MnSOD, CAT) and Survival After Treatment for Breast Cancer
Cancer Res.,
February 1, 2005;
65(3):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ahn, M. D. Gammon, R. M. Santella, M. M. Gaudet, J. A. Britton, S. L. Teitelbaum, M. B. Terry, A. I. Neugut, P. D. Josephy, and C. B. Ambrosone
Myeloperoxidase Genotype, Fruit and Vegetable Consumption, and Breast Cancer Risk
Cancer Res.,
October 15, 2004;
64(20):
7634 - 7639.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. P. Kumar, F. J. Piedrafita, and W. F. Reynolds
Peroxisome Proliferator-activated Receptor {gamma} Ligands Regulate Myeloperoxidase Expression in Macrophages by an Estrogen-dependent Mechanism Involving the -463GA Promoter Polymorphism
J. Biol. Chem.,
February 27, 2004;
279(9):
8300 - 8315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. E. Cayley Jr., F. W. Asselbergs, J.-W. Cohen Tervaert, R. A. Tio, M.-L. Brennan, M. S. Penn, and S. L. Hazen
Prognostic Value of Myeloperoxidase in Patients with Chest Pain
N. Engl. J. Med.,
January 29, 2004;
350(5):
516 - 518.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Makela, P. Dastidar, H. Jokela, M. Saarela, R. Punnonen, and T. Lehtimaki
Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Myeloperoxidase Promoter Polymorphism
J. Clin. Endocrinol. Metab.,
August 1, 2003;
88(8):
3823 - 3828.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. Henderson, J. Byun, J. Takeshita, and J. W. Heinecke
Phagocytes Produce 5-Chlorouracil and 5-Bromouracil, Two Mutagenic Products of Myeloperoxidase, in Human Inflammatory Tissue
J. Biol. Chem.,
June 20, 2003;
278(26):
23522 - 23528.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L.-L. Xu, G. Liu, D. P. Miller, W. Zhou, T. J. Lynch, J. C. Wain, L. Su, and D. C. Christiani
Counterpoint: The Myeloperoxidase -463G->A Polymorphism Does Not Decrease Lung Cancer Susceptibility in Caucasians
Cancer Epidemiol. Biomarkers Prev.,
December 1, 2002;
11(12):
1555 - 1559.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. Rocha, R. F. Franco, R. Porcher, H. Bittencourt, W. A. Silva Jr, A. Latouche, A. Devergie, H. Esperou, P. Ribaud, G. Socie, et al.
Host defense and inflammatory gene polymorphisms are associated with outcomes after HLA-identical sibling bone marrow transplantation
Blood,
December 1, 2002;
100(12):
3908 - 3918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W.F. Reynolds, M. Hiltunen, M. Pirskanen, A. Mannermaa, S. Helisalmi, M. Lehtovirta, I. Alafuzoff, and a. H. Soininen
MPO and APOE{epsilon}4 polymorphisms interact to increase risk for AD in Finnish males
Neurology,
November 14, 2000;
55(9):
1284 - 1290.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Naoe, K. Takeyama, T. Yokozawa, H. Kiyoi, M. Seto, N. Uike, T. Ino, A. Utsunomiya, A. Maruta, I. Jin-nai, et al.
Analysis of Genetic Polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese Patients with Therapy-related Leukemia/Myelodysplastic Syndrome and de novo Acute Myeloid Leukemia
Clin. Cancer Res.,
October 1, 2000;
6(10):
4091 - 4095.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
A. Van der Vliet, M. N. Nguyen, M. K. Shigenaga, J. P. Eiserich, G. P. Marelich, and C. E. Cross
Myeloperoxidase and protein oxidation in cystic fibrosis
Am J Physiol Lung Cell Mol Physiol,
September 1, 2000;
279(3):
L537 - L546.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. B. Schabath, M. R. Spitz, X. Zhang, G. L. Delclos, and X. Wu
Genetic variants of myeloperoxidase and lung cancer risk
Carcinogenesis,
June 1, 2000;
21(6):
1163 - 1166.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Le Marchand, A. Seifried, A. Lum, and L. R. Wilkens
Association of the Myeloperoxidase -463G{->}A Polymorphism with Lung Cancer Risk
Cancer Epidemiol. Biomarkers Prev.,
February 1, 2000;
9(2):
181 - 184.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
I. Cascorbi, S. Henning, J. Brockmöller, J. Gephart, C. Meisel, J. M. Müller, R. Loddenkemper, and I. Roots
Substantially Reduced Risk of Cancer of the Aerodigestive Tract in Subjects with Variant -463A of the Myeloperoxidase Gene
Cancer Res.,
February 1, 2000;
60(3):
644 - 649.
[Abstract]
[Full Text]
|
|
|
|
|
|
|
J. P. Henderson, J. Byun, M. V. Williams, D. M. Mueller, M. L. McCormick, and J. W. Heinecke
Production of Brominating Intermediates by Myeloperoxidase. A TRANSHALOGENATION PATHWAY FOR GENERATING MUTAGENIC NUCLEOBASES DURING INFLAMMATION
J. Biol. Chem.,
March 9, 2001;
276(11):
7867 - 7875.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
